Back

Moderate intensity continuous and high intensity interval training as strategy cardioprotective on cardiotoxicity induced by cancer. Randomized clinical trial

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Chronic heart failure - Epidemiology, prognosis, outcome 3 Rehabilitation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Jorge Antonio Lara Vargas

ISSSTE 20 DE NOVIEMBRE, Ciudad de Mexico (Mexico)

6 More presentations in this session

Presentation thumbnail
Temporal trends in infection-related hospitalizations in patients with heart failure: A nationwide study from 1997-2017
Ms S. Lundberg (Gentofte, DK)
Abstract Slides
Presentation thumbnail
Legacy effects of infection in patients with heart failure: a national cohort study of 31,318 patients in Taiwan
Doctor C. Chen (Tainan, TW)
Abstract Slides
Presentation thumbnail
The impact of self-care behaviour on health-related quality of life across functional dependency phenotipes: insights from a real-world cohort of 1120 patients with chronic heart failure
Doctor M. Ras Jimenez (Hospitalet De Llobregat, ES)
Abstract Slides
Presentation thumbnail
Heart failure admission to a cardiology department versus other internal medicine department is associated with improved long-term survival
Doctor P. Myhre (Oslo, NO)
Abstract Slides
Presentation thumbnail
Aortic valve calcium in relation to subclinical cardiac dysfunction and risk of heart failure in the general population
Mrs F. Zhu (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - Epidemiology, prognosis, outcome 3

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Case 1: a patient with ischaemic HFrEF
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources